Royal Bank of Canada’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $616M | Buy |
|
|||||
|
2025
Q1 | $586M | Sell |
|
|||||
|
2024
Q4 | $584M | Sell |
|
|||||
|
2024
Q3 | $729M | Sell |
|
|||||
|
2024
Q2 | $788M | Buy |
|
|||||
|
2024
Q1 | $632M | Buy |
|
|||||
|
2023
Q4 | $592M | Buy |
|
|||||
|
2023
Q3 | $428M | Buy |
|
|||||
|
2023
Q2 | $428M | Buy |
|
|||||
|
2023
Q1 | $355M | Buy |
|
|||||
|
2022
Q4 | $277M | Buy |
|
|||||
|
2022
Q3 | $267M | Buy |
|
|||||
|
2022
Q2 | $249M | Buy |
|
|||||
|
2022
Q1 | $219M | Buy |
|
|||||
|
2021
Q4 | $155M | Sell |
|
|||||
|
2021
Q3 | $142M | Sell |
|
|||||
|
2021
Q2 | $216M | Buy |
|
|||||
|
2021
Q1 | $181M | Sell |
|
|||||
|
2020
Q4 | $207M | Buy |
|
|||||
|
2020
Q3 | $199M | Buy |
|
|||||
|
2020
Q2 | $169M | Buy |
|
|||||
|
2020
Q1 | $127M | Sell |
|
|||||
|
2019
Q4 | $142M | Buy |
|
|||||
|
2019
Q3 | $103M | Buy |
|
|||||
|
2019
Q2 | $94.7M | Buy |
|
|||||
|
2019
Q1 | $94.1M | Sell |
|
|||||
|
2018
Q4 | $105M | Buy |
|
|||||
|
2018
Q3 | $109M | Buy |
|
|||||
|
2018
Q2 | $84.4M | Sell |
|
|||||
|
2018
Q1 | $92.5M | Buy |
|
|||||
|
2017
Q4 | $50.2M | Buy |
|
|||||
|
2017
Q3 | $24.9M | Buy |
|
|||||
|
2017
Q2 | $18.3M | Buy |
|
|||||
|
2017
Q1 | $9.27M | Sell |
|
|||||
|
2016
Q4 | $8.53M | Sell |
|
|||||
|
2016
Q3 | $14M | Buy |
|
|||||
|
2016
Q2 | $11.3M | Buy |
|
|||||
|
2016
Q1 | $9.89M | Buy |
|
|||||
|
2015
Q4 | $15.5M | Buy |
|
|||||
|
2015
Q3 | $10M | Sell |
|
|||||
|
2015
Q2 | $16.4M | Buy |
|
|||||
|
2015
Q1 | $12.3M | Sell |
|
|||||
|
2014
Q4 | $20.9M | Sell |
|
|||||
|
2014
Q3 | $44M | Buy |
|
|||||
|
2014
Q2 | $12.6M | Sell |
|
|||||
|
2014
Q1 | $12.8M | Sell |
|
|||||
|
2013
Q4 | $18.9M | Buy |
|
|||||
|
2013
Q3 | $15.6M | Buy |
|
|||||
|
2013
Q2 | $11.2M | Buy |
|